The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles
- PMID: 8553570
- DOI: 10.1006/viro.1995.0079
The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles
Abstract
Vpr is one of the auxiliary gene products encoded by HIV-1 genome. Vpr is a 14-kDa protein and exhibits several interesting characteristics including incorporation into virus particles, oligomerization, localization in the nucleus, and positive regulation of virus replication in primary cells. In an effort to define the structure-function relationship of Vpr, the role of the C-terminus of Vpr was investigated. Site-specific mutagenesis involving deletion, insertion, and substitution of residues at the C-terminus was utilized to generate variants of Vpr. Mutations introduced at the C-terminus affected properties of Vpr in different ways: (i) Vpr containing amino acids 1-72 showed the virion incorporation phenotype, indicating that the C-terminus is not essential for this function, (ii) the C-terminus contributes to the stability of Vpr, and (iii) substitution mutagenesis involving the basic residues showed stability similar to that of wild type, indicating the lack of involvement of these residues in this biochemical property of Vpr. The data generated in this study and our early mutagenic analyses on Vpr suggest that domains noncontiguous in primary sequence contribute to the stability of Vpr through overall conformation of the protein.
Similar articles
-
Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation.Virology. 1995 Feb 20;207(1):297-302. doi: 10.1006/viro.1995.1081. Virology. 1995. PMID: 7871742
-
Arginine residues in the C-terminus of HIV-1 Vpr are important for nuclear localization and cell cycle arrest.Virology. 1998 Mar 15;242(2):414-24. doi: 10.1006/viro.1998.9028. Virology. 1998. PMID: 9514978
-
Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Sep 1;10(1):1-7. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7648278
-
HIV-1 Vpr: genetic diversity and functional features from the perspective of structure.DNA Cell Biol. 2004 Apr;23(4):207-22. doi: 10.1089/104454904773819798. DNA Cell Biol. 2004. PMID: 15142378 Review.
-
Vpr and Its Cellular Interaction Partners: R We There Yet?Cells. 2019 Oct 24;8(11):1310. doi: 10.3390/cells8111310. Cells. 2019. PMID: 31652959 Free PMC article. Review.
Cited by
-
Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr.J Virol. 2000 Nov;74(22):10650-7. doi: 10.1128/jvi.74.22.10650-10657.2000. J Virol. 2000. PMID: 11044109 Free PMC article.
-
Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.Cell Mol Life Sci. 2012 Apr;69(8):1211-59. doi: 10.1007/s00018-011-0859-3. Epub 2011 Oct 28. Cell Mol Life Sci. 2012. PMID: 22033837 Free PMC article. Review.
-
Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.J Virol. 2001 Jun;75(12):5504-17. doi: 10.1128/JVI.75.12.5504-5517.2001. J Virol. 2001. PMID: 11356958 Free PMC article.
-
Evidence of Divergent Amino Acid Usage in Comparative Analyses of R5- and X4-Associated HIV-1 Vpr Sequences.Int J Genomics. 2017;2017:4081585. doi: 10.1155/2017/4081585. Epub 2017 May 17. Int J Genomics. 2017. PMID: 28620613 Free PMC article.
-
Development of a novel anti-HIV-1 agent from within: effect of chimeric Vpr-containing protease cleavage site residues on virus replication.Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3346-51. doi: 10.1073/pnas.94.7.3346. Proc Natl Acad Sci U S A. 1997. PMID: 9096396 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials